AGP Executive Report
Last update: 8 hours agoBiotech Licensing: Innovent Biologics agreed an exclusive deal worth up to $1.1bn with Spero Therapeutics for IBI355 (SP001), a third-generation anti-CD40L antibody, with Spero holding rights worldwide except Mainland China, Hong Kong, Macau and Taiwan; Spero targets a global Phase II in Q2 2027 for IgG4-related disease while Innovent plans a China Phase II for Sjögren’s disease. Macao Tech & Health: A UM team developed technology to turn sewage sludge into valuable resources, including sodium alginate for construction repair and additives for fish feed, aiming for commercialization within two years after safety tests. AI in Schools (Macao): St Magdalene School launched Macau’s first AI-powered exercise and health classroom with MPU and Beijing E-Way, using a “closed-loop” assessment system to generate tailored exercise plans under professional supervision. Drone Skills for GBA: Zhuhai Lianzhou Airport started a cross-border drone pilot training program for Hong Kong and Macau residents, targeting Greater Bay Area low-altitude opportunities and CAAC licensing. Food Safety (Macau): IAM ordered Healer Bar in Macau to suspend operations for rectification after Salmonella was found in a repeat food sample, following earlier microbiological non-compliance. Local Jobs & AI Upskilling (Macao): Macau’s Youth Employment Expo at Macau Tower offers 1,600+ vacancies from local and Hengqin firms, with online career assessments encouraging AI skills. Cross-border Medical Innovation: A Hengqin-Macao tie-up is pushing medical innovation, while Hengqin’s connectivity continues to deepen.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
